Neurology

New guidelines seek to address inconsistency in the approach to treatment.

Multiple sclerosis patients are increasingly using supplements to treat their depression symptoms.

Reduced sleep duration is linked to more repetitive negative thinking.

Significant research progress occurred in 2014, offering new leads that are driving efforts to stop MS, restore function lost, and end MS forever. Here is a brief summary of the research highlights reflecting the Society's commitment to pursue promising opportunities wherever they exist, while focusing on three priority areas: progressive MS, nervous system repair, and wellness/lifestyle, which have been singled out under each research goal below when applicable.

Activist and award-winning actress Madeleine Stowe recently went public about her late father's battle with multiple sclerosis, revealing to fans that she's nothing like the scheming Victoria Grayson who she portrays on ABC's hit show "Revenge." And this winter, Stowe will continue to share her inspiring story and insights about growing up in a family impacted by MS as she embarks on a tour across the country to meet people living with MS who will likewise share their experiences with the disease. The events will feature leading neurologists, lifestyle experts and people living with MS who are taking action in their own unique ways.

Novartis announced its analysis of fingolimod in primary-progressive multiple sclerosis (PPMS) resulted in no significant difference from placebo, according to its phase 3 INFORMS study.

A patient with multiple sclerosis who was taking dimethyl fumarate developed a rare and serious brain infection called progressive multifocal leukoencephalopathy and died, according to the FDA.

The majority of people with dementia have never seen a doctor about their memory and thinking problems.

What do lawyers and social workers have in common? According to a new study published in Neurology, these 2 kinds of workers may perform better on cognitive testing in their later years compared with those working in less stimulating jobs.

People whose jobs require more complex work with other people, such as social workers and lawyers, or with data, like architects or graphic designers, may end up having longer-lasting memory and thinking abilities compared to people who do less complex work.

More than 40% of calls placed to US poison control centers concerning energy drinks involve children under age 6, some of whom suffer serious cardiac and neurological symptoms.

The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.

Medication nonadherence is often disastrous for bipolar patients, as it can lead to poor impulse control, increased risk of hospitalization, and even suicide.

A dendritic cell vaccine for MS attacks the condition early, while preserving the immune system.

The FDA is permitting marketing of a replaceable urinary prosthesis for female adults with impaired detrusor contractility.

Neuroprotective nutrients appear to enhance cognition, memory, and other impaired functions seen in patients with Alzheimer's disease.

In response to the recent article by Gary M. Franklin, MD, MPH, titled "Opioids for chronic non-cancer pain: A position paper of the American Academy of Neurology," we wish to address a number of issues.

Sleep disorders may require independent diagnosis and management, researchers say.

A metaanalysis shows that levels of an antioxidative endogenous metabolic byproduct-uric acid-are correlated with disease activity in multiple sclerosis.

Adding panobinostat to a combination treatment of bortezomib and dexamethasone in heavily pretreated patients boosts progression-free survival, but overall survival data are not yet mature.

The results of an FDA safety review of omalizumab (Xolair) suggest the asthma drug slightly elevates the risk of serious cardiovascular and cerebrovascular adverse events.

Clinical pharmacists can reduce anti-epileptic drug (AED) prescription errors that commonly result from incomplete or poor documentation.

Disease modifying therapy maintains effects of interferon in the body for a longer duration.

In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.

Postmenopausal women who consume adequate amounts of potassium have reduced stroke risk.